Company intelligence / Profile preview

Merlin Nexus

New York, New York, United Statesadviserinfo.sec.gov ↗

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Merlin Nexus is an investment management firm specializing in crossover private equity investing within the life sciences sector. The company manages several funds and invests globally in both private and public healthcare companies, with a focus on biotech, pharma, medical devices, and related fields. It has participated in significant funding rounds for companies such as Zymeworks, Adaptimmune, Sunesis Pharmaceuticals, Cancervax/Micromet, and Xencor

Industry: Investors

Partnerships

Zymeworks Inc.Adaptimmune Ltd.Sunesis PharmaceuticalsCancervax/MicrometXencor

Beyond the preview

Go deeper on Merlin Nexus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merlin Nexus.

Explore the full profile